{"id":"https://openalex.org/W2127512142","doi":"https://doi.org/10.1186/1744-9081-6-34","title":"Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design","display_name":"Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2127512142","doi":"https://doi.org/10.1186/1744-9081-6-34","mag":"2127512142","pmid":"https://pubmed.ncbi.nlm.nih.gov/20576091","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2908054"},"language":"en","primary_location":{"id":"doi:10.1186/1744-9081-6-34","doi":"https://doi.org/10.1186/1744-9081-6-34","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1744-9081-6-34","pdf_url":"https://behavioralandbrainfunctions.biomedcentral.com/counter/pdf/10.1186/1744-9081-6-34","source":{"id":"https://openalex.org/S202417740","display_name":"Behavioral and Brain Functions","issn_l":"1744-9081","issn":["1744-9081"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioral and Brain Functions","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://behavioralandbrainfunctions.biomedcentral.com/counter/pdf/10.1186/1744-9081-6-34","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018605669","display_name":"Timothy L. Wigal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Timothy Wigal","raw_affiliation_strings":["Department of Pediatrics, University of California, Irvine, Child Development Center, Irvine, CA, USA. tlwigal@uci.edu","Department of Pediatrics, University of California, Irvine, Child Development Center, Irvine, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, University of California, Irvine, Child Development Center, Irvine, CA, USA. tlwigal@uci.edu","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Department of Pediatrics, University of California, Irvine, Child Development Center, Irvine, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799090","display_name":"Matthew N. Brams","orcid":"https://orcid.org/0000-0002-7926-6113","observed_orcids":["https://orcid.org/0000-0002-7926-6113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Brams","raw_affiliation_strings":["Private Practice, Bayou City Research, Houston, TX, USA","Private Practice, Bayou City Research, Houston, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Private Practice, Bayou City Research, Houston, TX, USA","institution_ids":[]},{"raw_affiliation_string":"Private Practice, Bayou City Research, Houston, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003133423","display_name":"Maria Gasior","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Gasior","raw_affiliation_strings":["Global Clinical Medicine, Shire Development Inc., Wayne, PA, USA","Global Clinical Medicine, Shire Development Inc., Wayne, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Medicine, Shire Development Inc., Wayne, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Global Clinical Medicine, Shire Development Inc., Wayne, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101108686","display_name":"Joseph Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Gao","raw_affiliation_strings":["Biostats, Shire Development Inc., Wayne, PA, USA","Biostats, Shire Development Inc., Wayne, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostats, Shire Development Inc., Wayne, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Biostats, Shire Development Inc., Wayne, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039645834","display_name":"Liza A. Squires","orcid":"https://orcid.org/0009-0004-6886-0020","observed_orcids":["https://orcid.org/0009-0004-6886-0020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Liza Squires","raw_affiliation_strings":["Global Clinical Medicine, Shire Development Inc., Wayne, PA, USA","Global Clinical Medicine, Shire Development Inc., Wayne, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Clinical Medicine, Shire Development Inc., Wayne, PA, USA","institution_ids":[]},{"raw_affiliation_string":"Global Clinical Medicine, Shire Development Inc., Wayne, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066479347","display_name":"John Giblin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Giblin","raw_affiliation_strings":["Clinical Study Centers, LLC, Little Rock, AR, USA","Clinical Study Centers, LLC, Little Rock, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Study Centers, LLC, Little Rock, AR, USA","institution_ids":[]},{"raw_affiliation_string":"Clinical Study Centers, LLC, Little Rock, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"316 Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"316 Study Group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018605669"],"corresponding_institution_ids":["https://openalex.org/I204250578"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":9.5928,"has_fulltext":true,"cited_by_count":138,"citation_normalized_percentile":{"value":0.98604016,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"6","issue":"1","first_page":"34","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11953","display_name":"Neuroethics, Human Enhancement, Biomedical Innovations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lisdexamfetamine-dimesylate","display_name":"lisdexamfetamine dimesylate","score":0.996999979019165},{"id":"https://openalex.org/keywords/attention-deficit-hyperactivity-disorder","display_name":"attention deficit hyperactivity disorder","score":0.9020000100135803},{"id":"https://openalex.org/keywords/adult-adhd","display_name":"adult ADHD","score":0.781000018119812},{"id":"https://openalex.org/keywords/sustained-attention","display_name":"sustained attention","score":0.4020000100135803},{"id":"https://openalex.org/keywords/adhd-rs-iv","display_name":"ADHD-RS-IV","score":0.8899999856948853},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.9160000085830688},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5210000276565552},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.49300000071525574},{"id":"https://openalex.org/keywords/crossover-design","display_name":"crossover design","score":0.33899998664855957},{"id":"https://openalex.org/keywords/long-term-efficacy-and-safety","display_name":"long-term efficacy and safety","score":0.5450000166893005},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.46700000762939453},{"id":"https://openalex.org/keywords/electrocardiography","display_name":"electrocardiogram","score":0.5170000195503235},{"id":"https://openalex.org/keywords/vital-signs","display_name":"vital signs","score":0.9279999732971191},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7757670879364014},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6831352710723877},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5533996820449829},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5491786003112793},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.5004959106445312},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4986732006072998},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4548022449016571},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38287580013275146},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.37516486644744873},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25996118783950806},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2294718325138092},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069478","descriptor_name":"Lisdexamfetamine Dimesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001289","descriptor_name":"Attention Deficit Disorder with Hyperactivity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003913","descriptor_name":"Dextroamphetamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014937","descriptor_name":"Work","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.1186/1744-9081-6-34","doi":"https://doi.org/10.1186/1744-9081-6-34","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1744-9081-6-34","pdf_url":"https://behavioralandbrainfunctions.biomedcentral.com/counter/pdf/10.1186/1744-9081-6-34","source":{"id":"https://openalex.org/S202417740","display_name":"Behavioral and Brain Functions","issn_l":"1744-9081","issn":["1744-9081"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioral and Brain Functions","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2908054","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2908054","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behav Brain Funct","raw_type":"Text"},{"id":"pmid:20576091","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20576091","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioral and brain functions : BBF","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.355.2144","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.355.2144","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/17/fb/Behav_Brain_Funct_2010_Jun_24_6_34.tar.gz","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:4b73957afbc74cbca3533b6b8c243bff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/4b73957afbc74cbca3533b6b8c243bff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Behavioral and Brain Functions, Vol 6, Iss 1, p 34 (2010)","raw_type":"article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt4kq3z3hd","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/4kq3z3hd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Behavioral and Brain Functions, vol 6, iss 1","raw_type":"article"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt7361234p","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/7361234p","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Behavioral and Brain Functions, vol 6, iss 1","raw_type":"article"},{"id":"pmh:qt4kq3z3hd","doi":null,"is_oa":false,"landing_page_url":"http://www.escholarship.org/uc/item/4kq3z3hd","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Wigal, Timothy; Brams, Matthew; Gasior, Maria; Gao, Joseph; Squires, Liza; Giblin, John; \u00c2\u00a0et al.(2010). Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design. Behavioral and Brain Functions, 6(1), 34. doi: http://dx.doi.org/10.1186/1744-9081-6-34. Retrieved from: http://www.escholarship.org/uc/item/4kq3z3hd","raw_type":"article"},{"id":"mag:2182452737","doi":null,"is_oa":false,"landing_page_url":"https://link.springer.com/content/pdf/10.1186/1744-9081-6-34.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1186/1744-9081-6-34","doi":"https://doi.org/10.1186/1744-9081-6-34","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1744-9081-6-34","pdf_url":"https://behavioralandbrainfunctions.biomedcentral.com/counter/pdf/10.1186/1744-9081-6-34","source":{"id":"https://openalex.org/S202417740","display_name":"Behavioral and Brain Functions","issn_l":"1744-9081","issn":["1744-9081"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Behavioral and Brain Functions","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2127512142.pdf","grobid_xml":"https://content.openalex.org/works/W2127512142.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W85852026","https://openalex.org/W629283852","https://openalex.org/W1968752176","https://openalex.org/W1973129436","https://openalex.org/W1974896478","https://openalex.org/W1979206088","https://openalex.org/W1986046877","https://openalex.org/W1989428478","https://openalex.org/W1992488678","https://openalex.org/W1999461973","https://openalex.org/W2009357282","https://openalex.org/W2016496786","https://openalex.org/W2018801193","https://openalex.org/W2023262882","https://openalex.org/W2030446955","https://openalex.org/W2047554178","https://openalex.org/W2052824975","https://openalex.org/W2058432412","https://openalex.org/W2061059960","https://openalex.org/W2062714266","https://openalex.org/W2064340252","https://openalex.org/W2076504554","https://openalex.org/W2094244099","https://openalex.org/W2111135575","https://openalex.org/W2129155589","https://openalex.org/W2129620184","https://openalex.org/W2148978240","https://openalex.org/W2159184227","https://openalex.org/W2159881136","https://openalex.org/W2164676183","https://openalex.org/W2169861403","https://openalex.org/W3090293687","https://openalex.org/W3183198605","https://openalex.org/W3215125900"],"related_works":["https://openalex.org/W2182452737","https://openalex.org/W7096651025","https://openalex.org/W2319564505","https://openalex.org/W7096738340","https://openalex.org/W1979206088","https://openalex.org/W2023262882","https://openalex.org/W2131679908","https://openalex.org/W2146800281","https://openalex.org/W2116799993","https://openalex.org/W2129620184"],"abstract_inverted_index":{"BACKGROUND:":[0],"Duration":[1],"of":[2,6,52,284],"efficacy":[3,195],"and":[4,60,72,80,91,103,116,160,227,249,279],"safety":[5],"lisdexamfetamine":[7],"dimesylate":[8],"(LDX)":[9,287],"was":[10],"assessed":[11],"in":[12,112,133,142,204,269,288],"adults":[13,126,187,238,270],"(18-55":[14],"years)":[15],"with":[16,32,86,271],"attention-deficit/hyperactivity":[17],"disorder":[18],"(ADHD)":[19,294],"using":[20],"the":[21,48,113,119,202,253,256],"simulated":[22],"adult":[23,87],"workplace":[24],"environment.":[25],"METHODS:":[26],"After":[27],"open-label":[28],"dose":[29,219],"optimization":[30,220],"(4-week)":[31],"LDX,":[33],"30-70":[34],"mg/d,":[35],"subjects":[36],"entered":[37],"a":[38],"2-week":[39],"randomized,":[40],"double-blind,":[41],"placebo-controlled":[42],"crossover":[43,92,235],"phase.":[44],"Efficacy":[45,280],"assessments":[46,95],"included":[47,96],"Permanent":[49],"Product":[50],"Measure":[51],"Performance":[53],"(PERMP)":[54],"total":[55,136,172,211],"score":[56],"(attempted+correct)":[57],"measured":[58,139],"predose":[59,163],"from":[61,162,181,255],"2":[62,182],"to":[63,183,260],"14":[64,184],"hours":[65],"postdose,":[66],"averaged":[67],"across":[68],"postdose":[69,178,264],"sessions":[70],"(primary)":[71],"at":[73,89,176],"each":[74,157,168],"time":[75,158,169,179,265],"point":[76,266],"vs":[77,124,191,196,247,267],"placebo":[78,197,248,268],"(secondary),":[79],"ADHD":[81],"Rating":[82],"Scale":[83],"IV":[84],"(ADHD-RS-IV)":[85],"prompts":[88],"baseline":[90],"visits.":[93],"Safety":[94,278],"treatment-emergent":[97],"adverse":[98],"events":[99],"(TEAEs),":[100],"vital":[101],"signs,":[102],"electrocardiograms.":[104],"RESULTS:":[105],"Of":[106],"127":[107],"randomized":[108],"subjects,":[109],"105":[110],"were":[111,174,221,232],"intention-to-treat":[114],"population":[115],"103":[117],"completed":[118],"study.":[120],"While":[121],"receiving":[122,189,239],"LDX":[123,190,193,242],"placebo,":[125],"had":[127],"greater":[128,175],"improvement":[129,251],"(P":[130,153,164,198],"<":[131,165,199],".0001)":[132,200],"average":[134],"PERMP":[135,171,245],"scores":[137,173,246],"as":[138],"by":[140,201],"difference":[141,203],"least":[143],"squares":[144],"(LS)":[145],"mean":[146,206],"(95%":[147,207],"CI):":[148],"23.4":[149],"(15.6,":[150],"31.2).":[151],"Absolute":[152],"<or=":[154],".0017":[155],"for":[156,167,186,209,237],"point)":[159,170],"change":[161],".001":[166],"all":[177],"points":[180],"h":[185],"while":[188],"placebo.":[192],"demonstrated":[194],"LS":[205],"CI)":[208],"ADHD-RS-IV":[210],"scores:":[212],"-11.5":[213],"(-14.2,":[214],"-8.9).":[215],"TEAEs":[216,230],"(>or=10%)":[217],"during":[218,234],"decreased":[222],"appetite,":[223],"dry":[224],"mouth,":[225],"headache,":[226],"insomnia;":[228],"no":[229],">or=5%":[231],"reported":[233],"phase":[236],"LDX.":[240],"CONCLUSIONS:":[241],"significantly":[243],"improved":[244],"maintained":[250],"throughout":[252],"day":[254],"first":[257],"(2":[258],"hours)":[259,263],"last":[261],"(14":[262],"ADHD.":[272],"TRIAL":[273],"REGISTRATION:":[274],"ClinicalTrials.gov":[275],"Identifier:":[276],"NCT00697515.":[277],"Workplace":[281],"Environment":[282],"Study":[283],"Lisdexamfetamine":[285],"Dimesylate":[286],"Adults":[289],"With":[290],"Attention-Deficit":[291],"Hyperactivity":[292],"Disorder":[293],"http://www.clinicaltrials.gov/ct2/show/NCT00697515?term=NCT00697515&rank=1.":[295]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}